Bibliography

Export 23 results:

Filters: Keyword is Immunosuppressive Agents / adverse effects [Clear All Filters]

2010

Kang SJ, Park KH, Jung SI, Jang HC, Ji SY, Ahn JS, et al. Scrub typhus induced by peripheral blood stem cell transplantation in the immunocompromised patient: diagnostic usefulness of nested polymerase chain reaction. Transfusion. 2010;50(2):467-70.

2005

Kalble T, Lucan M, Nicita G, Sells R, Burgos Revilla FJ, Wiesel M. EAU guidelines on renal transplantation. Eur Urol. 2005;47(2):156-66.

Buell JF, Gross TG, Woodle ES. Malignancy after transplantation. Transplantation. 2005;80(2 Suppl):S254-64.

2004

Morath C, Mueller M, Goldschmidt H, Schwenger V, Opelz G, Zeier M. Malignancy in renal transplantation. J Am Soc Nephrol. 2004;15(6):1582-8.

Trofe J, Beebe TM, Buell JF, Hanaway MJ, First MR, Alloway RR, et al. Posttransplant malignancy. Prog Transplant. 2004;14(3):193-200.

Miller MB, Hendren R, Gilligan PH. Posttransplantation disseminated coccidioidomycosis acquired from donor lungs. J Clin Microbiol. 2004;42(5):2347-9.

2000

Nakatsuji Y, Sugai F, Watanabe S, Kaido M, Koguchi K, Abe K, et al. HTLV-I-associated myelopathy manifested after renal transplantation. J Neurol Sci. 2000;177(2):154-6.

1998

Deeg HJ, Socie G. Malignancies after hematopoietic stem cell transplantation: many questions, some answers. Blood. 1998;91(6):1833-44.

1996

Colina F, Lopez-Rios F, Lumbreras C, Martinez-Laso J, Garcia IG, Moreno-Gonzalez E. Kaposi's sarcoma developing in a liver graft. Transplantation. 1996;61(12):1779-1781.

Oda D, Persson GR, Haigh WG, Sabath DE, Penn I, Aziz S. Oral presentation of posttransplantation lymphoproliferative disorders. An unusual manifestation. Transplantation. 1996;61(3):435-40.

1994

Penn I. Depressed immunity and the development of cancer. Cancer Detect Prev. 1994;18(4):241-52.

Heinz-Peer G, Helbich T, Nottling B, Klauser R, Muhlbacher F, Hubsch P. Renal cell carcinoma in an allograft kidney transplant. Transplantation. 1994;57(3):475-8.

1993

Penn I. Tumors after renal and cardiac transplantation. Hematol Oncol Clin North Am. 1993;7(2):431-45.

1986

Penn I, First MR. Development and incidence of cancer following cyclosporine therapy. Transplant Proc. 1986;18(2 Suppl 1):210-5.

1980

Venizelos PC, Lopata M, Bardawil WA, Sharp JT. Respiratory failure due to Strongyloides stercoralis in a patient with a renal transplant. Chest. 1980;78(1):104-6.

1979

Penn I. Kaposi's sarcoma in organ transplant recipients: report of 20 cases. Transplantation. 1979;27(1):8-11.

1978

Penn I. Development of cancer in transplantation patients. Adv Surg. 1978;12:155-91.

1977

Penn I. Transplantation in patients with primary renal malignancies. Transplantation. 1977;24(6):424-34.

1975

Penn I. Malignant disease in immunodeficient states in man. Recent Results Cancer Res. 1975;(52):96-106.

1974

Penn I. Malignancies in recipients of organ transplants. Johns Hopkins Med J Suppl. 1974;3:211-21.

1972

Penn I, Durst AL, Machado M, Halgrimson CG, S., Bynon J. J, Putman CW, et al. Acute pancreatitis and hyperamylasemia in renal homograft recipients. Arch Surg. 1972;105(2):167-72.

1971

Penn I, Bunch D, Olenik D, Abouna G. Psychiatric experience with patients receiving renal nad hepatic transplants. Semin Psychiatry. 1971;3(1):133-44.

1968

Penn I, Groth CG, Brettshneider L, J., Harris D. J, Marchioro TL, Starzi TE. Surgically correctable intra-abdominal complications before and after renal homotransplantation. Ann Surg. 1968;168(5):865-70.